Literature DB >> 970768

Felty's syndrome: granulocyte-bound immunoglobulin G and splenectomy.

G Logue.   

Abstract

A quantitative antiglobulin consumption technique was used to measure immunoglobulin G (IgG) present on human granulocytes. Granulocytes from 50 normal subjects had less than 20 X 10(-14) g IgG per cell. Patients with granulocytopenia due to bone-marrow failure, patients with IgG multiple myeloma, patients with splenomegaly, and patients with rheumatoid arthritis without granulocytopenia had granulocyte-bound IgG within the range of normal. Four patients with rheumatoid arthritis, splenomegaly, and severe granulocytopenia (Felty's syndrome) had granulocyte-bound IgG between 30 and 220 X 10(-14) g IgG per cell. One of these patients underwent splenectomy, after which his granulocyte-bound IgG fell to normal. Seven additional patients with Felty's syndrome who had previously undergone splenectomy had normal levels of granulocyte-bound IgG. Thus quantitation of granulocyte-bound IgG appears to be useful in defining patients with immunologically mediated granulocytopenia. Studies of patients with Felty's syndrome who have undergone splenectomy suggest that the spleen may produce this neutrophile-bound immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970768     DOI: 10.7326/0003-4819-85-4-437

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes.

Authors:  G L Logue; H J Cohen
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Suppressor cell-mediated neutropenia in Felty's syndrome.

Authors:  N I Abdou; C NaPombejara; L Balentine; N L Abdou
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  High-dose immunoglobulin in Felty's syndrome.

Authors:  M Ahern; J Harkness; P Maddison; S Forskitt
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

4.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Passive haemagglutination inhibition for quantitation of red cell associated IgG.

Authors:  H I Atrah; J G Templeton; R J Crawford; G S Gabra; R Mitchell
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

6.  Cell mediated autoimmune granulocytopenia in a case of Felty's syndrome.

Authors:  S Slavin; M H Liang
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

7.  Felty's syndrome associated with high levels of IgA rheumatoid factor.

Authors:  R H Withrington; I Teitsson; M H Seifert; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

8.  Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome.

Authors:  G Starkebaum; J W Singer; W P Arend
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.

Authors:  G Starkebaum; W P Arend
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

10.  Long-term outcome in Felty's syndrome.

Authors:  C Thorne; M B Urowitz
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.